Fenwick corporate governance practice co-chair David Bell talked to Automotive News about the complexity of public companies’ decisions about how much to disclose regarding a chief executive’s health in the context of sick leave during the COVID 19 pandemic.
Bell told Automotive News that many companies opt to say as little as possible about a CEO's health.
"It may be risky to make an incomplete disclosure. And again, when you're trying to balance somebody's privacy interests and the risk to the company, that leans people toward not making disclosure," Bell noted.
For more information, please read the alert that Bell co-authored on when a company should disclose the news that a senior leader has a serious health challenge.
The full article is available on Automotive News (subscription required).